In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Somanetics Corp.

www.somanetics.net

Latest From Somanetics Corp.

Tight Glycemic Control: Critical Care’s Balancing Act

Over a decade ago, the New England Journal of Medicine published a study identifying tight glycemic control in the intensive care unit as a critical step to improving patient outcomes. Today, a small pack of companies is trying to finally deliver on the promise.

Medical Device

Tight Glycemic Control: Critical Care’s Balancing Act

Over a decade ago, the New England Journal of Medicine published a study identifying tight glycemic control in the intensive care unit as a critical step to improving outcomes. Today, GlySure and others are working on continuous glucose monitoring for the critical care environment to help deliver on that promise.

Medical Device

Medical Device Market & Industry Briefs, April 2012

Brief summaries of recent medtech market and industry developments. This month we cover Covidien’s continuing buying spree, and other medtech M&A.

Medical Device Deals

Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q2 2010

Highlights from the Q1 2010 review of medical device and in vitro diagnostics/research dealmaking: With most of the funding in the form of venture rounds, medical device financing totaled $548 million in the second quarter, a 10% drop from Q1. Device acquisitions picked up, with 18 transactions completed for an aggregate $4.4 billion. Including GenMark's IPO, the first done in the sector since November 2007, in vitro diagnostic/research financing more than doubled Q1's dollar volume, reaching $364 million in the second quarter. The four IVD/Research acquisitions done in Q2 totalled $226 million.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Somanetics Corp.
  • Senior Management
  • Bruce J Barrett, Pres. & CEO
    William M Iacona, VP, CFO
    Arik Anderson, SVP, R&D
    Dominic J Spadafore, VP, US Sales & Mktg.
  • Contact Info
  • Somanetics Corp.
    Phone: (248) 244-1400
    2600 Troy Center Dr.
    Troy, MI 48083-4208
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register